Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,793 signal articles · 261 in last 24h · 118,151 total before filter · latest 39m ago
261last 24h
1590last 7d
251● bullish (7d)
161● bearish (7d)
205publishers
AllMacro307Earnings649M&A93Regulatory28Product13Analyst24
✕ clear all filterssentiment: bearishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Samsung (KOSE:A005930) Faces ITC Memory Probe While Expanding Into US Senior Care
Simply Wall St.31d agobearish
Samsung (KOSE:A005930) Faces ITC Memory Probe While Expanding Into US Senior Care

The US International Trade Commission opened an investigation into Samsung Electronics over Netlist patent infringement claims tied to certain high bandwidth memory and DDR5 products. A separate multi year partnership was announced with Lark Health to offer preventive and chronic care services to US seniors through Samsung Health and the company’s device ecosystem. Samsung Electronics, KOSE:A005930, is drawing attention as fresh legal and business developments hit the headlines at the same...

Rocket Lab (RKLB) Expands Launch Infrastructure To Support More Frequent Missions
Simply Wall St.31d agobearish
Rocket Lab (RKLB) Expands Launch Infrastructure To Support More Frequent Missions

Rocket Lab is expanding its launch infrastructure footprint, adding capacity across ground systems, mission control, and launch sites. The build out is aimed at supporting higher launch frequency and a broader mix of commercial and national security customers. The company plans to use the expanded facilities to handle more complex missions and provide more responsive access to space. For investors tracking Rocket Lab, listed as NasdaqGS:RKLB, the infrastructure build out sits alongside a...

SELLAS Life Sciences Group (SLS) Stock Looks Rich On Book Value Yet Strong On Returns
Simply Wall St.31d agobearish
SELLAS Life Sciences Group (SLS) Stock Looks Rich On Book Value Yet Strong On Returns

SELLAS Life Sciences Group has delivered a very large 3 year return, yet the stock currently screens as expensive on broad valuation checks. This sets up a clear tension between recent share price strength and what the fundamentals suggest about value. Over 3 years, the stock has returned close to 7x, which puts extra focus on whether that gain is supported by fundamentals or mainly by sentiment. Expectations for strong revenue and earnings growth, combined with a sizeable shelf registration...

Has CRISPR Therapeutics (CRSP) Fallen Far Enough To Look Undervalued?
Simply Wall St.31d agobearish
Has CRISPR Therapeutics (CRSP) Fallen Far Enough To Look Undervalued?

CRISPR Therapeutics stock has delivered a decline of about 61% over the past five years, yet current valuation checks suggest the shares now sit closer to "about right" territory rather than looking clearly cheap or clearly expensive. The roughly 60.9% five year share price decline points to investors reassessing how much they are willing to pay for CRISPR Therapeutics' long term gene editing opportunity. Strong cash of around US$2.4b that has been highlighted in recent coverage can support...

SELLAS Life Sciences Group (SLS) Stock Pricey Following Phase 3 Trial Buzz
Simply Wall St.31d agobearish
SELLAS Life Sciences Group (SLS) Stock Pricey Following Phase 3 Trial Buzz

SELLAS Life Sciences Group (SLS) is drawing focused attention as its Phase 3 trial for galinpepimut-S in acute myeloid leukemia approaches the required events for an overall survival readout, a key catalyst for the stock. See our latest analysis for SELLAS Life Sciences Group. At a latest share price of $13.19, SELLAS Life Sciences Group has seen a 69.97% 1 month share price return and a 203.22% year to date share price return. The 1 year total shareholder return is very large, signaling that...

NANO Nuclear Energy (NNE) Stock Fair Value Falls As Analysts Weigh Growth Against Execution Risk
Simply Wall St.32d agobearish
NANO Nuclear Energy (NNE) Stock Fair Value Falls As Analysts Weigh Growth Against Execution Risk

The latest analyst update for NANO Nuclear Energy resets fair value from US$46.67 to US$41.40, an 11% move that puts fresh numbers around a still early stage story. This shift lines up with a split analyst backdrop, where some highlight long term potential in micro modular reactors, while others focus on execution risk and the timing of key projects. As you read on, you will see how this evolving narrative shapes the way analysts frame opportunity, risk, and what to watch next. Analyst Price...

Do Lucid Group’s (LCID) Denials and Lawsuits Reframe the Story on Governance and Liquidity?
Simply Wall St.32d agobearish
Do Lucid Group’s (LCID) Denials and Lawsuits Reframe the Story on Governance and Liquidity?

In recent days, Lucid Group has repeatedly denied rumors that it is considering bankruptcy or going private, explaining that adviser AlixPartners is focused on operational improvements rather than restructuring and that existing liquidity is sufficient to fund operations well into next year. At the same time, multiple securities class action filings over concealed Gravity SUV delivery issues and halted guidance underscore ongoing questions about Lucid’s governance, disclosure practices, and...

Wall St ends lower for the day and week as chip selloff broadens
Reuters Videos32d agobearishVIDEO
Wall St ends lower for the day and week as chip selloff broadens

<body><p>STORY: Wall Street ended the week with another down day on Friday, as the Dow dropped more than three-quarters of a percent, the S&P 500 shed 1% and the Nasdaq lost 1.4%.</p><p>All three indexes also posted weekly losses.</p><p>Semiconductor shares initially led the selloff, which broadened as the session progressed.</p><p>The Philadelphia Semiconductor Index, while still up about 65% year-to-date, logged its steepest weekly loss in over a year this week, and has tumbled nearly 18% so far in July.&nbsp;</p><p>Eric Lynch, managing director & co-portfolio manager at Suncoast Equity Management, said the decline reflects investor jitters over billions in AI-related spending.</p><p>"You're seeing just continued consternation surrounding, 'Hey, what's the ETA on this return on investment?' Right? And when TSMC [Taiwan Semiconductor Manufacturing Company], the fab [fabrication] company, reported this week, they said, "Look, things are great, but we're going to be building 15% even higher CapEx than we guided for, and our revenues are going to go up not quite as much as that,' in terms of the increase in guidance. So investors were concerned. And so it's probably going to be really important to see what the hyperscalers do this earnings season. Microsoft, Google, Amazon - are they seeing revenues that are actually in line or, ahead of, their CapEx, or not?”</p><p>:: Netflix</p><p>Elsewhere in the market, shares of&nbsp;Netflix tumbled more than 7% after the streaming giant's weaker-than-expected earnings forecast, raising doubts about the sustainability of the content growth momentum.</p><p>Shares of Uber dropped 2% after the ridesharing service announced it would acquire Germany's Delivery Hero in a deal worth nearly $15 billion.</p><p>:: Intuitive Surgical&nbsp;</p><p>And shares of Intuitive Surgical plunged 14% after the company maintained its global growth forecast for procedures performed with its da Vinci surgical robots, and warned that changes to some insurance plans could hurt demand.</p></body>